Adequate protein helps support: Muscle maintenance Metabolism Exercise recovery Blood sugar management Fullness and satiety Many people taking GLP-1 medications also experience early fullness, nausea, or reduced interest in food, which can unintentionally lower protein intake
Research on GLP-1 Use in People With Bipolar Disorder Is Limited The original randomized, controlled trials for GLP-1s often didnt include participants with bipolar disorder, notes the nonprofit International Bipolar Foundation
Vitamin B Complex 1,250 mg: Maintains skin health and glow
Kim TS, Lee HS, Chung JW
Novo Nordisk has argued that as the first amylin-based combination on the market, CagriSema will carry the strongest weight-loss label of any product available at its anticipated launch date, and that the amylin mechanism which suppresses post-meal glucagon through a pathway distinct from GLP-1 offers a differentiated clinical profile
Our providers guide you through every step, ensuring you understand the benefits and any potential risks